Studies have reported a significant decrease in the activity of protein phosphatase 1 (PP1) and protein phosphatase 5 (PP5) by approximately 20% in the brains of AD patients, whereas protein phosphatase-2A (PP2A) exhibits an even greater reduction of approximately 50% [62]. This evidence concerns the gene PTPA and Alzheimer disease.